Idexx Laboratories IDXX Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.
The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Idexx Laboratories's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Idexx Laboratories's stock issuance proceeds?
- Idexx Laboratories (IDXX) reported stock issuance proceeds of $18.16M in Q1 2026.
- How has Idexx Laboratories's stock issuance proceeds changed year-over-year?
- Idexx Laboratories's stock issuance proceeds increased by 152.5% year-over-year, from $7.19M to $18.16M.
- What is the long-term trend for Idexx Laboratories's stock issuance proceeds?
- Over 4 years (2021 to 2025), Idexx Laboratories's stock issuance proceeds has grown at a 19.0% compound annual growth rate (CAGR), from $46.57M to $93.36M.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.